Progressive myoclonus epilepsy in Gaucher Disease due to a new Gly–Gly mutation causing loss of an Exonic Splicing Enhancer

[1]  M. Horowitz,et al.  New Directions in Gaucher Disease , 2016, Human mutation.

[2]  R. Guerrini,et al.  Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations , 2016, Molecular Therapy: Nucleic Acids.

[3]  J. Swensen,et al.  The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer , 2016, PLoS genetics.

[4]  S. Mooney,et al.  Clinical relevance of short-chain acyl-CoA dehydrogenase (SCAD) deficiency: Exploring the role of new variants including the first SCAD-disease-causing allele carrying a synonymous mutation , 2016, BBA clinical.

[5]  R. Guerrini,et al.  When silence is noise: infantile‐onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription , 2016, Clinical genetics.

[6]  Chava Kimchi-Sarfaty,et al.  Exposing synonymous mutations. , 2014, Trends in genetics : TIG.

[7]  C. Rosano,et al.  Functional analysis of 11 novel GBA alleles , 2013, European Journal of Human Genetics.

[8]  T. Berkelman,et al.  A Defined Methodology for Reliable Quantification of Western Blot Data , 2013, Molecular Biotechnology.

[9]  Ellen Sidransky,et al.  The link between the GBA gene and parkinsonism , 2012, The Lancet Neurology.

[10]  C. Kimchi-Sarfaty,et al.  Understanding the contribution of synonymous mutations to human disease , 2011, Nature Reviews Genetics.

[11]  E. Dardiotis,et al.  β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease. , 2011, Molecular genetics and metabolism.

[12]  M. Horowitz,et al.  The enigma of the E326K mutation in acid β-glucocerebrosidase. , 2011, Molecular genetics and metabolism.

[13]  L. Bour,et al.  A monozygotic twin pair with highly discordant Gaucher phenotypes. , 2011, Blood cells, molecules & diseases.

[14]  E. Sidransky,et al.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) , 2008, Human mutation.

[15]  M. Horowitz,et al.  ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. , 2007, Human molecular genetics.

[16]  K. Hodaňová,et al.  Genetic and clinical features of patients with Gaucher disease in Hungary. , 2007, Blood cells, molecules & diseases.

[17]  E. Sobreira,et al.  Detection of 12 new mutations in Gaucher disease Brazilian patients. , 2006, Blood cells, molecules & diseases.

[18]  B. Bembi,et al.  Characterization of two novel GBA mutations causing Gaucher disease that lead to aberrant RNA species by using functional splicing assays , 2006, Human mutation.

[19]  M. Horowitz,et al.  ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity , 2005 .

[20]  S. Grossi,et al.  Early Visual Seizures and Progressive Myoclonus Epilepsy in Neuronopathic Gaucher Disease Due to a Rare Compound Heterozygosity (N188S/S107L) , 2004, Epilepsia.

[21]  D. Grinberg,et al.  Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and “modifier” polymorphisms , 2004, Human mutation.

[22]  J. D. den Dunnen,et al.  Standardizing mutation nomenclature: Why bother? , 2003, Human mutation.

[23]  R. Schiffmann,et al.  Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3. , 2003, The Journal of pediatrics.

[24]  J. Sussman,et al.  X‐ray structure of human acid‐β‐glucosidase, the defective enzyme in Gaucher disease , 2003, EMBO reports.

[25]  Ellen Sidransky,et al.  Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease. , 2003, American journal of human genetics.

[26]  R. Schiffmann,et al.  Myoclonic Epilepsy in Gaucher Disease: Genotype-Phenotype Insights from a Rare Patient Subgroup , 2003, Pediatric Research.

[27]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[28]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[29]  J. K. Park,et al.  Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. , 2000, American journal of human genetics.

[30]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[31]  J. Sobrino,et al.  Unusual expression of Gaucher's disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation. , 1995, Journal of medical genetics.

[32]  E. Beutler,et al.  Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Ginns,et al.  Isolation of cDNA clones for human β-glucocerebrosidase using the λgtll expression system , 1984 .

[34]  R. Glew,et al.  beta-Glucosidase assays in the diagnosis of Gaucher's disease. , 1982, Clinical chemistry.

[35]  S. Raghavan,et al.  Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease. , 1980, American journal of human genetics.

[36]  N. Higurashi,et al.  Gaucher disease patient with myoclonus epilepsy and a novel mutation. , 2010, Pediatric neurology.

[37]  Jong-Won Kim,et al.  Gaucher disease: Identification of three new mutations in the Korean and Chinese (Taiwanese) populations , 1996, Human mutation.

[38]  O. Reiner,et al.  The human glucocerebrosidase gene and pseudogene: structure and evolution. , 1989, Genomics.

[39]  R. Van Tiggelen,et al.  Gaucher disease , 2019, Haematology.

[40]  E. Ginns,et al.  Isolation of cDNA clones for human beta-glucocerebrosidase using the lambda gt11 expression system. , 1984, Biochemical and biophysical research communications.